Skip to main content
. 2016 Apr 28;42(5):608–617. doi: 10.1097/DSS.0000000000000755

Figure 4.

Figure 4

Improvement from baseline in eyebrow fullness (A) and eyebrow darkness (B) by visit (intent-to-treat population). Bim, bimatoprost.